When suffering increases: accompanying illnesses with headache
The World Health Organisation (WHO) counts migraine as one of the most severely disabling illnesses affecting humanity; in general, headache disorders are a great burden to those affected by them. In addition, people suffering from headaches or migraine have a higher risk of developing further illnesses or problems alongside their headache disorder. Emerging research is focusing increasingly on so-called comorbidity with headache and migraine. This article presents the newest findings in this field.
Extensive studies show an increased risk for people with headaches
An extensive review from 2021 analysed data from 139 studies from the years 2000 to 2020, which involved over 4.2 million people with headaches: accompanying illnesses with headache and migraine were reported in 2.7 million cases. The most commonly named comorbidities were depressive disorders, high blood pressure, and anxiety disorders. After the intensive research of the past decades it can be regarded as certain that primary headache disorders are connected or associated with a variety of comorbidities. This means that people suffering from a primary headache disorder are fundamentally at a higher risk of certain accompanying illnesses. Primary headache disorders are independent disorders, which distinguishes them from secondary headaches. The latter frequently occur as a consequence of other illnesses or injuries, for example, as a side effect of concussion or advanced sinusitis. By far the most common primary headache disorders are migraine and tension-type headache.
Correct diagnosis of comorbidities: indispensable and yet very rare
The examined studies show that accompanying illnesses for headaches are often not diagnosed correctly and are attributed to the underlying headache. For example, symptoms of anxiety or depressive disorders are often not recognised as such, which in turn makes targeted treatment impossible. The analysis shows that treating doctors often have too little awareness or knowledge of accompanying illnesses for headaches and that patients are not getting the support for their symptoms that would help them. This can have serious consequences for affected people, because a holistic diagnosis which takes all relevant factors into consideration can lessen their suffering and significantly increase their quality of life.
The accompanying illnesses are varied
People affected by primary headache disorders were found to have around 20% higher prevalences of depression and anxiety than the headache-free population. Younger rather than older and female rather than male patients are particularly severely affected. The most commonly occurring psychiatric comorbidities were anxiety (25%), depression (23%), and post-traumatic stress disorder (15%) – migraine patients are particularly affected here. In addition, physical illnesses such as high blood pressure also occur at a higher rate, although older age groups and male patients are more severely affected by these. Heart and circulation disorders form a significant part of the accompanying illnesses for headaches. Thus, migraine (especially migraine with aura) in young women puts them at significant risk of a stroke. Ischemic heart diseases also occur more frequently in migraine patients than in the average population.
The negative impacts on affected people increase with psychiatric comorbidities
A newer study from 2020 considers the degree of personal impairment which affected people experience through their migraine in relation to the additional impairment from accompanying psychiatric illnesses. For this, they used the so-called MIDAS grading, a parameter established in medical practice which shows the individual levels of impairment for people with headaches. The proportion of patients with a MIDAS grade showing a moderate to severe impairment was around 28% for “migraine only” patients. If they also had anxiety, this rose to 43%, and to 51% with depression. For people with migraine with both accompanying illnesses, the proportion rose to 61%. This data shows a measurable, significant increase in the suffering of migraine patients who experience psychiatric illnesses in addition to their primary headache disorder.
A vicious cycle of headache and comorbidity
We must pay particular attention to the fact that primary headache disorders and accompanying issues can influence each other. Researchers have long considered anxiety and depression states as undisputed triggers of migraine attacks. When they occur simultaneously as a result of regular headaches, it becomes clear how closely headaches and accompanying illnesses are interlinked. The same problem is apparent with sleeping disorders. Sleeping disorders very frequently occur in parallel with headache disorders; relevant studies state that the average prevalence is 48%. On the one hand, sleeping disorders can function as a trigger for headaches, on the other hand, studies describe that frequent headaches are a significant disruptive factor for restful sleep. This, in turn, has a strong influence on mental wellbeing, as sleeping problems can, among other things, lead to accompanying depressive illnesses long-term.
Sustainable prevention can be effective in many ways
The above statement is supported by the longstanding maxim that good sleep hygiene must be a central pillar in the prevention of headaches and migraine, and also shows its relevance for their accompanying illnesses. Generally, we can see from the aforementioned studies that the sustainable prevention of migraine and headaches does not simply prevent the primary illnesses themselves, but can also indirectly prevent a variety of potential accompanying symptoms. The lighter the burden of headaches, the lower the risk of potential comorbidities and their mutual causation. At the same time, the medical care of the affected people needs to be rethought, so that strenuous accompanying symptoms can be reliably recognised and treated in a targeted manner, and so that particularly those who are worst affected are not left alone with their many ailments.
-
REFERENCES
read
Altamura C, Corbelli I, de Tommaso M, Di Lorenzo C, Di Lorenzo G, Di Renzo A, Filippi M, Jannini TB, Messina R, Parisi P, Parisi V, Pierelli F, Rainero I, Raucci U, Rubino E, Sarchielli P, Li L, Vernieri F, Vollono C, Coppola G. Pathophysiological Bases of Comorbidity in Migraine. Front Hum Neurosci. 2021 Apr 20;15:640574. doi: 10.3389/fnhum.2021.640574.
Caponnetto V, Deodato M, Robotti M, Koutsokera M, Pozzilli V, Galati C, Nocera G, De Matteis E, De Vanna G, Fellini E, Halili G, Martinelli D, Nalli G, Serratore S, Tramacere I, Martelletti P, Raggi A; European Headache Federation School of Advanced Studies (EHF-SAS). Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain. 2021 Jul 14;22(1):71. doi: 10.1186/s10194-021-01281-z.
Galvez-Sánchez CM, Montoro Aguilar CI. Migraine and Neuroticism: A Scoping Review. Behav Sci (Basel). 2022 Jan 28;12(2):30. doi: 10.3390/bs12020030. PMID: 35200282; PMCID: PMC8869701.
Garrigós-Pedrón M, Segura-Ortí E, Gracia-Naya M, La Touche R. Predictive factors of sleep quality in patients with chronic migraine. Neurologia (Engl Ed). 2022 Mar;37(2):101-109. doi: 10.1016/j.nrleng.2018.11.009. Epub 2021 Feb 4. PMID: 35279224.
Hubbard CS, Khan SA, Keaser ML, Mathur VA, Goyal M, Semi-nowicz DA. Altered brain structure and function correlate withdisease severity and pain catastrophizing in migraine patients.eNeuro [Internet]. 2014;1:e20, 14.60
Kikui S, Chen Y, Ikeda K, Hasebe M, Asao K, Takeshima T. Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey. BMJ Open. 2022 Nov 30;12(11):e065787. doi: 10.1136/bmjopen-2022-065787. PMID: 36450434; PMCID: PMC9716839.
Kim J, Lee S, Rhew K. Association between Gastrointestinal Diseases and Migraine. Int J Environ Res Public Health. 2022 Mar 28;19(7):4018. doi: 10.3390/ijerph19074018. PMID: 35409704; PMCID: PMC8997650.
Lipton RB, Fanning KM, Buse DC, Martin VT, Hohaia LB, Adams AM, Reed ML, Goadsby PJ. Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study. Neurology. 2019 Dec 10;93(24):e2224-e2236. doi: 10.1212/WNL.0000000000008589. Epub 2019 Nov 5.
Lipton RB, Seng EK, Chu MK, Reed ML, Fanning KM, Adams AM, Buse DC. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2020 Sep;60(8):1683-1696. doi: 10.1111/head.13914. Epub 2020 Aug 16.
Peres MFP, Mercante JPP, Tobo PR, Kamei H, Bigal ME. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain. 2017 Dec;18(1):37. doi: 10.1186/s10194-017-0742-1. Epub 2017 Mar 21.
Richer L, Wong KO, Martins KJB, Rajapakse T, Amoozegar F, Becker WJ, Klarenbach SW. Characteristics of Adults with Migraine in Alberta, Canada: A Population-Based Study. Can J Neurol Sci. 2022 Mar;49(2):239-248. doi: 10.1017/cjn.2021.68. Epub 2021 Apr 13. PMID: 33845936.
close